Publications

Rapports annuels

Nous vous envoyons volontiers les rapports annuels précédents sur demande.

Publications scientifiques

Nous vous envoyons volontiers les articles suivants sur demande.

  • Enzmann C, Steiner L, Pospieszny K, et al. A Multicenter Cross-Sectional Study of the Swiss Cohort of LAMA2-Related Muscular Dystrophy. J Neuromuscul Dis. 2024;11(5):1021-1033. PMC11380305 Résumé: News
  • Steiner L, Tscherter A, Henzi B, Branca M, Carda S, Enzmann C, Fluss J, Jacquier D, Neuwirth C, Ripellino P, et al. Chronic Pain in Patients with Spinal Muscular Atrophy in Switzerland: A Query to the Spinal Muscular Atrophy Registry. Journal of Clinical Medicine. 2024; 13(10). https://doi.org/10.3390/jcm13102798 Résumé: News
  •  Stettner, G. M., Hasselmann, O., Tscherter, A., Galiart, E., Jacquier, D., & Klein, A. (2023). Treatment of spinal muscular atrophy with Onasemnogene Abeparvovec in Switzerland: a prospective observational case series study. BMC neurology, 23(1), 88. https://doi.org/10.1186/s12883-023-03133-6 Résumé: News
  • Henzi, B. C., Baumann, D., Erni, S. J., Lötscher, N., Tscherter, A., Klein, A., & Swiss-Reg-NMD Group (2023). Effects of the COVID-19 Pandemic on Access to Education and Social Participation in Children and Adolescents with Duchenne Muscular Dystrophy in Switzerland. Neuropediatrics, 54(4), 287–291. https://doi.org/10.1055/s-0043-1764434 Résumé: News
  • Gruebner, O., van Haasteren, A., Hug, A., Elayan, S., Sykora, M., Albanese, E., Stettner, G. M., Waldboth, V., Messmer-Khosla, S., Enzmann, C., Baumann, D., von Wyl, V., Fadda, M., Wolf, M., & von Rhein, M. (2023). Mental health challenges and digital platform opportunities in patients and families affected by pediatric neuromuscular diseases – experiences from Switzerland. Digital health, 9, 20552076231213700. https://doi.org/10.1177/20552076231213700
  • Tscherter, A., Rüsch, C. T., Baumann, D., Enzmann, C., Hasselmann, O., Jacquier, D., Jung, H. H., Kruijshaar, M. E., Kuehni, C. E., Neuwirth, C., Stettner, G. M., Klein, A., & Swiss-Reg-NMD group (2022). Evaluation of real-life outcome data of patients with spinal muscular atrophy treated with nusinersen in Switzerland. Neuromuscular disorders : NMD, 32(5), 399–409. https://doi.org/10.1016/j.nmd.2022.02.001 Résumé: News
  • Koeks, Z., Bladen, C. L., Salgado, D., van Zwet, E., Pogoryelova, O., McMacken, G., Monges, S., Foncuberta, M. E., Kekou, K., Kosma, K., Dawkins, H., Lamont, L., Bellgard, M. I., Roy, A. J., Chamova, T., Guergueltcheva, V., Chan, S., Korngut, L., Campbell, C., Dai, Y., … Lochmüller, H. (2017). Clinical Outcomes in Duchenne Muscular Dystrophy: A Study of 5345 Patients from the TREAT-NMD DMD Global Database. Journal of neuromuscular diseases, 4(4), 293–306. https://doi.org/10.3233/JND-170280
  • Bladen, C. L., Thompson, R., Jackson, J. M., Garland, C., Wegel, C., Ambrosini, A., Pisano, P., Walter, M. C., Schreiber, O., Lusakowska, A., Jedrzejowska, M., Kostera-Pruszczyk, A., van der Pol, L., Wadman, R. I., Gredal, O., Karaduman, A., Topaloglu, H., Yilmaz, O., Matyushenko, V., Rasic, V. M., … Lochmüller, H. (2014). Mapping the differences in care for 5,000 spinal muscular atrophy patients, a survey of 24 national registries in North America, Australasia and Europe. Journal of neurology, 261(1), 152–163. https://doi.org/10.1007/s00415-013-7154-1